Search company, investor...

Founded Year

2009

Stage

Private Equity | Alive

Total Raised

$300M

Valuation

$0000 

Last Raised

$300M | 2 yrs ago

About Equashield

Equashield is a medical device company that specializes in the development and provision of Closed System Transfer Devices (CSTDs). The company's main offerings include a range of products designed for the safe handling of hazardous drugs, from the compounding process in pharmacies to administration in nursing settings. These products, which include closed syringes, adapters, connectors, and tubing sets, aim to protect healthcare workers from exposure to hazardous drugs and vapors. It was founded in 2009 and is based in Port Washington, New York.

Headquarters Location

2 Harbor Park Drive

Port Washington, New York, 11050,

United States

516-684-8200

Loading...

Loading...

Expert Collections containing Equashield

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Equashield is included in 1 Expert Collection, including Unicorns- Billion Dollar Startups.

U

Unicorns- Billion Dollar Startups

1,249 items

Equashield Patents

Equashield has filed 39 patents.

The 3 most popular patent topics include:

  • fluid dynamics
  • robotic manipulators
  • surgery
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/15/2018

9/10/2024

Computer connectors, Audiovisual connectors, Analog video connectors, Electrical signal connectors, DC power connectors

Grant

Application Date

11/15/2018

Grant Date

9/10/2024

Title

Related Topics

Computer connectors, Audiovisual connectors, Analog video connectors, Electrical signal connectors, DC power connectors

Status

Grant

Latest Equashield News

LONG ISLAND PRESS AND DAN'S PAPERS NAMES EQUASHIELD® A WINNER OF THE LONG ISLAND TOP WORKPLACES 2024 AWARD

Oct 3, 2024

News provided by Share this article Share toX PORT WASHINGTON, N.Y. , Oct. 3, 2024 /PRNewswire/ -- EQUASHIELD® has been awarded a Top Workplaces 2024 honor by Long Island Top Workplaces. This list is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage LLC. The confidential survey uniquely measures the employee experience and its component themes, including employees feeling Respected & Supported, Enabled to Grow, and Empowered to Execute, to name a few. EQUASHIELD® is a leading supplier of closed system transfer devices (CSTD), recognized for its proprietary Syringe Unit. The Syringe Unit is the only closed-back syringe unit available in the market. It has received FDA clearance for full-volume use. With 46% of EQUASHIELD®'s U.S. workforce based at its Port Washington headquarters, the company's administrative and warehouse teams are integral to distributing its critical safety products nationwide. Reflecting on the achievement, Armando Radelat, General Manager of EQUASHIELD®, said, "Being recognized as a top workplace for the second-year running is a tremendous honor. It speaks volumes about the dedication and passion of our team. Innovation and integrity are the core values that drive us, and this award reflects these principles in action." EQUASHIELD®'s strong workplace culture stems from several impactful initiatives, including robust employee development programs, an emphasis on transparent communication, and a strong focus on safety and operational efficiency. These efforts not only enhance employee satisfaction but also mirror the company's broader mission to provide safer environments for healthcare professionals. About EQUASHIELD® EQUASHIELD® in 2009, EQUASHIELD® compounding technologies is a globally recognized leading provider of manual and automated solutions for compounding and administration, committed to safeguarding healthcare professionals from exposure to hazardous drugs while increasing efficiency. EQUASHIELD®'s product suite includes its flagship CSTD and the Mundus Mini HD, a groundbreaker in safe automated compounding of hazardous drugs. EQUASHIELD CSTD is CE marked and FDA cleared for preventing microbial ingress for up to seven days and for full volume use of the syringe unit. Together the EQUASHIELD® CSTD and Mundus Mini HD redefine handling hazardous drugs, reducing the risk of exposure to hazardous drugs and simplifying workflows. For more information about EQUASHIELD® and its solutions, visit  www.equashield.com For media inquiries:

Equashield Frequently Asked Questions (FAQ)

  • When was Equashield founded?

    Equashield was founded in 2009.

  • Where is Equashield's headquarters?

    Equashield's headquarters is located at 2 Harbor Park Drive, Port Washington.

  • What is Equashield's latest funding round?

    Equashield's latest funding round is Private Equity.

  • How much did Equashield raise?

    Equashield raised a total of $300M.

  • Who are the investors of Equashield?

    Investors of Equashield include Nordic Capital.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.